REQUEST A DEMO
Total
USD $0.00
Search more companies

Atoz Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Atoz Pharmaceuticals Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Atoz Pharmaceuticals Private Limited is a company in India, with a head office in Kanchipuram. It operates in the Pharmaceutical and Medicine Manufacturing sector. Atoz Pharmaceuticals Private Limited was incorporated on February 12, 1998. From the latest financial highlights, Atoz Pharmaceuticals Private Limited reported a net sales revenue increase of 27.21% in 2023. There was a total growth of 20.04% in Atoz Pharmaceuticals Private Limited’s total assets over the same period. The net profit margin of Atoz Pharmaceuticals Private Limited decreased by 0.3% in 2023.

Legal Address
1/8,Balaji Nagar Westopp. Stead Ford Hosiptal Thirumullaivoyal
Kanchipuram; Tamil Nadu; Postal Code: 600053

Contact Details: Purchase the Atoz Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Atoz Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Atoz Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
February 12, 1998
Key Executives
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Atoz Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
27.21%
Total Operating Revenue
24.33%
Operating Profit
21.64%
EBITDA
19.43%
Net Profit/Loss for the Period
22.49%
Total Assets
20.04%
Total Equity
11.15%
Operating Profit Margin
-0.48%
Net Profit Margin
-0.3%
Return on Equity (ROE)
1.02%
Quick Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?